204 related articles for article (PubMed ID: 32436862)
81. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
82. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
[TBL] [Abstract][Full Text] [Related]
83. Downregulation of long noncoding RNA DGCR5 contributes to the proliferation, migration, and invasion of cervical cancer by activating Wnt signaling pathway.
Liu Y; Chang Y; Lu S; Xiang YY
J Cell Physiol; 2019 Jul; 234(7):11662-11669. PubMed ID: 30552671
[TBL] [Abstract][Full Text] [Related]
84. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
[TBL] [Abstract][Full Text] [Related]
85. MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6.
Shen W; Xie XY; Liu MR; Wang LL
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1957-1968. PubMed ID: 30915738
[TBL] [Abstract][Full Text] [Related]
86. RASA4 inhibits the HIFα signaling pathway to suppress proliferation of cervical cancer cells.
Chen J; Huang J; Huang Q; Li J; Chen E; Xu W
Bioengineered; 2021 Dec; 12(2):10723-10733. PubMed ID: 34752201
[TBL] [Abstract][Full Text] [Related]
87. Cervical Carcinoma: Oncobiology and Biomarkers.
Volkova LV; Pashov AI; Omelchuk NN
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830452
[TBL] [Abstract][Full Text] [Related]
88. HNF4A-BAP31-VDAC1 axis synchronously regulates cell proliferation and ferroptosis in gastric cancer.
Zhou Q; Liu T; Qian W; Ji J; Cai Q; Jin Y; Jiang J; Zhang J
Cell Death Dis; 2023 Jun; 14(6):356. PubMed ID: 37296105
[TBL] [Abstract][Full Text] [Related]
89. Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/ERK signaling.
Zhu K; Bai H; Mu M; Xue Y; Duan Z
FEBS Open Bio; 2021 Jul; 11(7):2041-2049. PubMed ID: 34081837
[TBL] [Abstract][Full Text] [Related]
90. A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma.
Guo-Qing P; Yuan Y; Cai-Gao Z; Hongling Y; Gonghua H; Yan T
J Exp Clin Cancer Res; 2010 Sep; 29(1):129. PubMed ID: 20846459
[TBL] [Abstract][Full Text] [Related]
91. Overexpression of Eukaryotic translation initiation factor 3D induces stem cell-like properties and metastasis in cervix cancer by activating FAK through inhibiting degradation of GRP78.
Zhong Y; Lan J
Bioengineered; 2022 Jan; 13(1):1952-1961. PubMed ID: 35104170
[TBL] [Abstract][Full Text] [Related]
92. Break the loop, escape the cycle?
van Amerongen R; Berns A
EMBO J; 2013 Jul; 32(14):1967-9. PubMed ID: 23749211
[TBL] [Abstract][Full Text] [Related]
93. Pan-Cancer Analysis of Voltage-Dependent Anion Channel (VDAC1) as a Cancer Therapeutic Target or Diagnostic Biomarker.
Wang Z; Cheng Y; Song Z; Zhao R
Dis Markers; 2022; 2022():5946110. PubMed ID: 35958281
[TBL] [Abstract][Full Text] [Related]
94. UCHL3 promotes cervical cancer development and metastasis by stabilizing NRF2 via deubiquitination.
Zhang Y; Liu JB; Liu J; Liu M; Liu HL; Zhang J
Biochem Biophys Res Commun; 2023 Jan; 641():132-138. PubMed ID: 36527747
[TBL] [Abstract][Full Text] [Related]
95. In silico study of the impact of oxidation on pyruvate transmission across the hVDAC1 protein channel.
Rezaei M; Ghasemitarei M; Razzokov J; Yusupov M; Ghorbanalilu M; Ejtehadi MR
Arch Biochem Biophys; 2024 Jan; 751():109835. PubMed ID: 38000492
[TBL] [Abstract][Full Text] [Related]
96. Voltage-Dependent Anion Channel 1 Expression in Oral Malignant and Premalignant Lesions.
Allon I; Pettesh J; Livoff A; Schlapobersky M; Nahlieli O; Michaeli E
Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046443
[TBL] [Abstract][Full Text] [Related]
97. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
98. SHCBP1 contributes to the proliferation and self‑renewal of cervical cancer cells and activation of the NF‑κB signaling pathway through EIF5A.
Deng B; Li A; Zhu Y; Zhou Y; Fei J; Miao Y
Oncol Lett; 2023 Jun; 25(6):246. PubMed ID: 37153055
[TBL] [Abstract][Full Text] [Related]
99. PLAC8 contributes to the malignant behaviors of cervical cancer cells by activating the SOX4-mediated AKT pathway.
Deng B; Zhang S; Zhou Y; Zhu Y; Fei J; Li A
Histochem Cell Biol; 2023 May; 159(5):439-451. PubMed ID: 36602585
[TBL] [Abstract][Full Text] [Related]
100. ZIC5 promotes aggressiveness and cancer stemness in cervical squamous cell carcinoma.
Jia Q; Song J; Xu T; Liu J; Chai J; Yang Y; Li L; Li M; Yang X
Pathol Res Pract; 2023 Jan; 241():154268. PubMed ID: 36495760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
